We are live on ! Find out more
UFF

USA Financial Formulas Portfolio holdings

AUM $531M
1-Year Est. Return 28.6%
This Fund
S&P 500
This Quarter Est. Return
+25.51%
1 Year Est. Return
+28.6%
3 Year Est. Return
+77.97%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$135M
AUM Growth
-$22.4M
Cap. Flow
-$46.8M
Cap. Flow %
-34.82%
Top 10 Hldgs %
38.49%
Holding
350
New
112
Increased
40
Reduced
54
Closed
93

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$4.38M
2
MNST icon
Monster Beverage
MNST
+$3.92M
3
DXCM icon
DexCom
DXCM
+$3M
4
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$2.59M
5
EA icon
Electronic Arts
EA
+$2.27M

Top Sells

Rank Stock Value
1
ANSS
Ansys
ANSS
+$3.85M
2
AMAT icon
Applied Materials
AMAT
+$3.56M
3
LRCX icon
Lam Research
LRCX
+$3.54M
4
BIIB icon
Biogen
BIIB
+$3.49M
5
FISV
Fiserv Inc
FISV
+$3.35M

Sector Composition

Rank Sector Weight
1 Healthcare 29.17%
2 Technology 24.33%
3 Communication Services 15.05%
4 Consumer Staples 8.01%
5 Real Estate 4.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ODFL icon
126
Old Dominion Freight Line
ODFL
$45.6B
$2K ﹤0.01%
+24
New +$1.82K
ORCL icon
127
Oracle
ORCL
$420B
$2K ﹤0.01%
+41
New +$2.17K
PAYX icon
128
Paychex
PAYX
$42.2B
$2K ﹤0.01%
+27
New +$1.87K
PYPL icon
129
PayPal
PYPL
$50.1B
$2K ﹤0.01%
+12
New +$1.66K
SHW icon
130
Sherwin-Williams
SHW
$87.8B
$2K ﹤0.01%
9
+6
+200% +$1.08K
SPGI icon
131
S&P Global
SPGI
$122B
$2K ﹤0.01%
7
-4,848
-100% -$1.46M
SRE icon
132
Sempra
SRE
$56.6B
$2K ﹤0.01%
28
-30
-52% -$1.84K
TGT icon
133
Target
TGT
$67.3B
$2K ﹤0.01%
18
+11
+157% +$1.25K
XYL icon
134
Xylem
XYL
$28.5B
$2K ﹤0.01%
+38
New +$2.51K
ABT icon
135
Abbott
ABT
$182B
$1K ﹤0.01%
+15
New +$1.36K
ADP icon
136
Automatic Data Processing
ADP
$108B
$1K ﹤0.01%
+8
New +$1.15K
ADSK icon
137
Autodesk
ADSK
$50.1B
$1K ﹤0.01%
+3
New +$590
AFL icon
138
Aflac
AFL
$63.7B
$1K ﹤0.01%
+24
New +$867
AMAT icon
139
Applied Materials
AMAT
$434B
$1K ﹤0.01%
11
-65,999
-100% -$3.56M
AME icon
140
Ametek
AME
$58.2B
$1K ﹤0.01%
+14
New +$1.17K
AMT icon
141
American Tower
AMT
$81.7B
$1K ﹤0.01%
2
– –
ANSS
142
DELISTED
Ansys
ANSS
$1K ﹤0.01%
2
-14,441
-100% -$3.85M
APA icon
143
APA Corp
APA
$12.7B
$1K ﹤0.01%
+71
New +$810
APD icon
144
Air Products & Chemicals
APD
$65.6B
$1K ﹤0.01%
5
+4
+400% +$913
APH icon
145
Amphenol
APH
$211B
$1K ﹤0.01%
+52
New +$1.16K
AWK icon
146
American Water Works
AWK
$26.6B
$1K ﹤0.01%
4
– –
BDX icon
147
Becton Dickinson
BDX
$46.9B
$1K ﹤0.01%
+5
New +$1.21K
BMY icon
148
Bristol-Myers Squibb
BMY
$135B
$1K ﹤0.01%
13
– –
BSX icon
149
Boston Scientific
BSX
$71.1B
$1K ﹤0.01%
+19
New +$684
CAH icon
150
Cardinal Health
CAH
$54.7B
$1K ﹤0.01%
+27
New +$1.39K
4 5
6
7 8

Similar funds

EPA
Element Pointe Advisors Miami, Florida $530M AUM 16.87% 1-Year Est. Return
TM
Taproot Management New York $530M AUM
KI
Kapitalo Investimentos Sao Paulo, Brazil $531M AUM 25.72% 1-Year Est. Return
PWS
Proactive Wealth Strategies Marietta, Georgia $532M AUM 21.29% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
SLC
Second Line Capital Metairie, Louisiana $528M AUM 16.68% 1-Year Est. Return
LSCM
Light Street Capital Management Palo Alto, California $534M AUM 59.08% 1-Year Est. Return
LIM
Lathrop Investment Management Little Rock, Arkansas $534M AUM 22.94% 1-Year Est. Return

USA Financial Formulas's Q2 2020 Portfolio in Review

As of Q2 2020, USA Financial Formulas held 350 positions worth $135M, down 14% from $157M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

USA Financial Formulas withdrew a net $46.8M in Q2 2020, closing 93 positions and reducing 54 holdings. Its most notable exit was Gilead Sciences, an estimated $3.34M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 15% a quarter earlier, followed by Technology and Communication Services.

Against the trend, USA Financial Formulas opened a new position in Johnson & Johnson worth $4.23M.

  • USA Financial Formulas's largest Q2 2020 buy was Johnson & Johnson: 30,087 shares worth $4.23M.
  • USA Financial Formulas added most to DexCom in Q2 2020, an estimated $3M increase.
  • USA Financial Formulas's biggest Q2 2020 reduction was Ansys, cutting an estimated $3.85M.
  • USA Financial Formulas fully exited Gilead Sciences in Q2 2020, selling an estimated $3.34M.
  • USA Financial Formulas's ten largest holdings make up 38% of its $135M portfolio in Q2 2020.
  • USA Financial Formulas opened 112 new positions and closed 93 in Q2 2020.
  • USA Financial Formulas's portfolio value fell 14% quarter-over-quarter to $135M.

Based on USA Financial Formulas's 13F filing for Q2 2020, filed 11 Aug 2020.